Navigation Links
Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program

Quincy Bioscience is pleased to be a sponsor of the annual fundraising MS Luncheons held in Wisconsin which help support families affected by MS and to be a corporate contributor to the MS Scholarship Program. Quincy Bioscience recently launched MS HOPE Trials which will investigate how its patented calcium-binding technology may help improve the quality of life for those with MS.

Madison, WI (Vocus) June 17, 2010 -- Quincy Bioscience is pleased to be a sponsor of the annual MS Luncheons held in Milwaukee and Madison and to be a corporate contributor to the MS Scholarship Program. The MS Luncheon is an annual fundraising event which showcases how donor support moves research forward and meets urgent needs in Wisconsin.

Quincy Bioscience has recently launched the MS HOPE Trial investigating how its patented calcium-binding technology may help improve the quality of life for those with MS at MS HOPE Trials.

The theme of the luncheon fundraisers is “My Cause. My Cure. My Commitment…to a world free of MS.” Funds raised through the luncheon support ground-breaking research into the cause, care and cure of MS, and services designed to address the challenges of living with MS.

The MS Scholarship Program was created to assist in making college dreams a reality for people with MS or their children, who are pursuing a post-secondary education and have demonstrated leadership, academic excellence and financial need.

“Living with MS can be incredibly challenging. The MS Luncheons create awareness and help support those diagnosed with MS as well as their families. Quincy Bioscience is working diligently to improve the outcomes of those with Multiple Sclerosis,” explains Mark Underwood, President of Quincy Bioscience.

About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Quincy Bioscience Launches; Research Studies More Accessible For Participants
2. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
3. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
4. Exalenz Bioscience Expands Market Coverage for the BreathID Breath Test System
5. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
6. Southridge LLC Provides Equity Capital Through Private Agreement with PuraMed Bioscience
7. Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
9. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
10. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
11. Thriving Bioscience Region Leaves Its Mark
Post Your Comments:
Related Image:
Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center ... and is the only hospital in the region providing what is known as ... transcatheter pacing patients were revealed recently at a medical conference and published in ...
(Date:12/1/2015)... MD (PRWEB) , ... December 01, 2015 , ... ... salmon identification tests to continue the expansion of the company’s growing product line ... – for Chinook (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... for Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or ... anticipated results, once a deal is signed. This quick-read guidance suggests that ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: